From GlobeNewswire: 2025-04-02 22:33:00

FibroBiologics, a biotechnology company, made significant progress in researching neurodegenerative diseases by demonstrating that intravenous fibroblasts can induce remyelination in the Cuprizone animal model. This study showed a statistically significant increase in myelin expression within seven weeks of treatment. This research confirms FibroBiologics’ earlier report on remyelination in the EAE animal model. The myelin sheath, crucial for nerve function, is often damaged in diseases like multiple sclerosis. These findings offer hope for patients with demyelinating diseases. FibroBiologics aims to develop transformative therapies targeting the root causes of chronic illnesses.



Read more at GlobeNewswire: FibroBiologics gibt wissenschaftlicher Fortschritte bei der